Corrigendum: Associations of Serum S100A12 With Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Prospective Cohort Study.

Jiang, Xiao; Huang, Chun-Mei; Feng, Chun-Mei; Xu, Zheng; Fu, Lin; Wang, Xin-Ming

Jiang, Xiao; Huang, Chun-Mei; Feng, Chun-Mei; Xu, Zheng; Fu, Lin; Wang, Xin-Ming.

Afiliação

Jiang X; Department of Nephrology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Huang CM; Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
Feng CM; Respiratory and Critical Care Medicine, Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Xu Z; Respiratory and Critical Care Medicine, Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Fu L; Respiratory and Critical Care Medicine, Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Wang XM; Department of Toxicology, Anhui Medical University, Hefei, China.

Front Immunol ; 12: 815903, 2021.

Article em En | MEDLINE | ID: mdl-35222356

RESUMO

[This corrects the article DOI: 10.3389/fimmu.2021.714026.].

Palavras-chave

CAP severity score; S100A12; biomarker; community-acquired pneumonia; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google